Case Reports in Pediatrics (Jan 2016)

Use of Zoledronic Acid in Paediatric Craniofacial Fibrous Dysplasia

  • Chiara Di Pede,
  • Sabrina Congedi,
  • Sara Rossin,
  • Antuan Divisic,
  • Alesandra De Gregorio,
  • Caterina Agosto,
  • Igor Catalano,
  • Alessandro Mazza,
  • Leonardo Sartori,
  • Stefano Masiero,
  • Franca Benini

DOI
https://doi.org/10.1155/2016/2329483
Journal volume & issue
Vol. 2016

Abstract

Read online

We describe a case of a paediatric patient affected by mandibular fibrous dysplasia (FD) with severe and chronic pain who was successfully treated with zoledronic acid (ZOL): a third-generation bisphosphonate. Further research is needed to assess its safety and efficacy as a treatment option for FD in the paediatric population.